
How a Digital Platform Is Bridging the Type 1 Diabetes Education Gap in Southeast Asia
A new multilingual online resource is reaching thousands of people across Cambodia, Vietnam, Thailand, and Malaysia with culturally relevant Type 1 diabetes information—filling a critical void in regions where healthcare access and education remain limited.
Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.
Key takeaways
- Southeast Asia faces significant barriers to Type 1 diabetes care, including limited healthcare infrastructure, few trained specialists, and a lack of education in local languages
- HelloType1, a digital platform launched between 2021 and 2023, grew from 1,178 users in 2021 to 40,361 in 2024
- The platform operates in multiple languages across four countries through partnerships with local healthcare providers and diabetes organizations
- Digital education tools may help address delayed diagnoses and reduce complications like diabetic ketoacidosis in regions with limited in-person resources
The Challenge: Limited Resources, Urgent Need
Type 1 diabetes in Southeast Asia remains underdiagnosed and undertreated. Countries across the region struggle with limited healthcare infrastructure, shortages of trained endocrinologists and diabetes educators, and inconsistent access to reliable information. Many people lack resources in their own language, making self-management even harder.
These gaps have real consequences. People with undiagnosed or poorly managed Type 1 diabetes face higher rates of diabetic ketoacidosis—a serious, potentially life-threatening condition—and inequitable access to the care they need.
A Digital Solution Takes Shape
During the COVID-19 pandemic, Action4Diabetes—a nonprofit organization—partnered with local healthcare professionals and diabetes associations to create HelloType1, a multilingual digital education platform. The goal was straightforward: provide accurate, culturally relevant Type 1 diabetes information to people who had few other options.
The platform launched in phases: Cambodia in 2021, Vietnam and Thailand in 2022, and Malaysia in 2023. Each launch was supported by formal agreements with local partners, embedding the resource within existing healthcare networks rather than imposing an outside solution.
Rapid Growth and Expanding Reach
Between 2021 and 2024, HelloType1 demonstrated significant growth. The number of unique website users grew from 1,178 in 2021 to 40,361 in 2024—a substantial increase in reach across the four countries.
Researchers analyzed website traffic and social media engagement to track how people were using the platform and which resources resonated most. The data showed consistent, growing interest in the tool over time and across different countries, suggesting the platform is meeting an identified need.
What This Means for the Community
While digital platforms cannot replace in-person care, they can fill critical gaps when healthcare resources are scarce. By offering trustworthy information in local languages, HelloType1 may help people recognize symptoms earlier, manage their diabetes more effectively, and feel less isolated.
The platform's growth and regional expansion suggest that culturally tailored digital education can work in Southeast Asia—and similar approaches may benefit other regions facing comparable barriers to diabetes care.
Evidence label
Source: JMIR formative research. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Related reading
More evidence-labeled coverage across the Type1Cure library.
- LifestyleSleep Problems in Teens With Type 1 Diabetes: What Research Shows
- LifestyleCGM Users Move More: What a New Study Reveals About Glucose Monitoring and Physical Activity
- LifestyleWhy Sleep Matters for Teens with Type 1 Diabetes—and What Gets in the Way
- LifestyleSleep Problems Are Common in Type 1 Diabetes—Here's What Research Found
- LifestyleWhat Research Shows About Type 1 Diabetes and Exercise Performance
- LifestyleA New App Aims to Make Type 1 Diabetes Management Less Overwhelming